a:3:{s:6:"_token";s:40:"lIDlh0Zo9hyYmRrQnz9aq821x2CGVA1JD4IMyR1f";s:9:"_previous";a:1:{s:3:"url";s:202:"https://www.pharmafocusasia.com/news/news_archives.asp?NewsID=47907&title=FDA-Approves-Bayers-Kogenate%C2%AE-FS-Antihemophilic-Factor-VIII-recombinant-for-Routine-Prophylaxis-in-Adults-with-Hemophilia-A";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}